OpenEvidence Raises $210M Series B to Power Clinical AI with Trusted Medical Knowledge

Used by hundreds of thousands of verified clinicians and active across over 10,000 hospitals and medical centers, OpenEvidence supports more than 40% of U.S. physicians in high-stakes decisions.

OpenEvidence Raises $210M Series B to Power Clinical AI with Trusted Medical Knowledge
Source: OpenEvidence

Company Name: OpenEvidence

Location: Cambridge, MA

Industry: Health AI / Clinical Decision Support

Funding Details:

  • Amount: $210M (Series B)
  • Investors:
    • Lead/Notable: Sequoia Capital, Coatue, Conviction, Thrive

Purpose of Investment:

  • Expand strategic content partnerships
  • Enhance the medical knowledge library powering clinical AI

Leadership:

Product:
OpenEvidence is a clinical decision support platform that equips healthcare professionals with instant, evidence-based answers at the point of care.

About Company:
Used by hundreds of thousands of verified clinicians and active across over 10,000 hospitals and medical centers, OpenEvidence supports more than 40% of U.S. physicians in high-stakes decisions. Its AI engine is powered by partnerships with the AMA (JAMA) and The New England Journal of Medicine, integrating gold-standard medical knowledge—including full-text and multimedia—into its clinical answers. The company has raised over $300M to date.

Ask ChatGPT

Read next